Published eLetters
Guidelines
As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.
Jump to comment:
- Page navigation anchor for A clarification of mouse behavioral dataA clarification of mouse behavioral data
The data in Figures 5B, C, and D in Steuer et al., 2022 and in Figures 5D, E, and F in Gamache et al., 2020 were acquired concurrently, but the figures reported different data and statistical analyses.
Steuer EL, Kemper LJ, Hlynialuk CJW, Leinonen-Wright K, Montonye ML, Lapcinski IP, Forster CL, Ashe KH, Liu P (2022) Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia. J Neurosci 42:4737–4754. https://doi.org/10.1523/JNEUROSCI.0543-22.2022
Gamache JE, Kemper L, Steuer E, Leinonen-Wright K, Choquette JM, Hlynialuk C, Benzow K, Vossel KA, Xia W, Koob MD, Ashe KH (2020) Developmental pathogenicity of 4-repeat human tau is lost with the P301L mutation in genetically matched tau-transgenic mice. J Neurosci 40:220–236. https://doi.org/10.1523/JNEUROSCI.1256-19.2019
Competing Interests: None declared.
